- Home
- OGEN vs DSS Comparison
OGEN vs DSS Comparison
Compare OGEN & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- DSS
- Stock Information
- Founded
- OGEN 1996
- DSS 1984
- Country
- OGEN United States
- DSS United States
- Employees
- OGEN N/A
- DSS N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- OGEN Health Care
- DSS Consumer Discretionary
- Exchange
- OGEN Nasdaq
- DSS Nasdaq
- Market Cap
- OGEN 9.8M
- DSS 10.0M
- IPO Year
- OGEN N/A
- DSS N/A
- Fundamental
- Price
- OGEN $0.52
- DSS $1.36
- Analyst Decision
- OGEN
- DSS
- Analyst Count
- OGEN 0
- DSS 0
- Target Price
- OGEN N/A
- DSS N/A
- AVG Volume (30 Days)
- OGEN 722.3K
- DSS 8.2K
- Earning Date
- OGEN 11-07-2024
- DSS 11-12-2024
- Dividend Yield
- OGEN N/A
- DSS N/A
- EPS Growth
- OGEN N/A
- DSS N/A
- EPS
- OGEN N/A
- DSS N/A
- Revenue
- OGEN $7,466.00
- DSS $19,276,000.00
- Revenue This Year
- OGEN N/A
- DSS N/A
- Revenue Next Year
- OGEN N/A
- DSS N/A
- P/E Ratio
- OGEN N/A
- DSS N/A
- Revenue Growth
- OGEN N/A
- DSS N/A
- 52 Week Low
- OGEN $0.47
- DSS $1.25
- 52 Week High
- OGEN $7.74
- DSS $4.82
- Technical
- Relative Strength Index (RSI)
- OGEN 37.47
- DSS 47.64
- Support Level
- OGEN $0.47
- DSS $1.25
- Resistance Level
- OGEN $1.29
- DSS $1.42
- Average True Range (ATR)
- OGEN 0.10
- DSS 0.07
- MACD
- OGEN -0.04
- DSS 0.01
- Stochastic Oscillator
- OGEN 7.84
- DSS 58.82
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.